IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q2 2013 Holdings

Filed 2013-08-14 | 29 holdings | $119.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$118.5M6,529,81099.5%
Acadia Pharmaceuticals Inc(ACAD)CallCOM004225108$90.8K5,000,0000.1%
Achillion Pharmaceuticals in(ACHNEUR)COM00448Q201$61.0K7,455,2020.1%
Keryx Biopharmaceuticals IncCOM492515101$42.3K5,659,2850.0%
Sangamo Biosciences Inc(SGMO)COM800677106$41.9K5,368,0940.0%
Dyax CorpCOM26746E103$37.7K10,908,3790.0%
Newlink Genetics CorpCOM651511107$36.3K1,840,2940.0%
Novavax IncCOM670002104$35.2K17,170,8010.0%
Therapeuticsmd IncCOM88338N107$34.1K11,262,6080.0%
Insmed Inc(INSM)COM PAR $.01457669307$29.1K2,433,3190.0%
Derma Sciences IncCOM PAR $.01249827502$26.6K1,994,8760.0%
Sunesis Pharmaceuticals IncCOM NEW867328601$24.5K4,716,2960.0%
Xoma Corp delCOM98419J107$24.3K6,698,5580.0%
Sangamo Biosciences Inc(SGMO)CallCOM800677106$23.4K3,000,0000.0%
Hyperion Therapeutics IncCOM44915N101$19.9K902,8580.0%
Receptos IncCOM756207106$19.4K975,0000.0%
Achillion Pharmaceuticals in(ACHNEUR)CallCOM00448Q201$16.4K2,000,0000.0%
Omeros Corp(OMER)COM682143102$14.9K2,953,0040.0%
Oncogenex Pharmaceuticals inCOM68230A106$8.5K863,3320.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$7.7K436,1450.0%
Keryx Biopharmaceuticals IncCallCOM492515101$7.5K1,000,0000.0%
Enzo Biochem Inc(ENZB)COM294100102$7.0K3,348,0290.0%
Dynavax Technologies CorpCOM268158102$6.6K6,000,0000.0%
Prothena Corp PLC(PRTA)SHSG72800108$6.4K497,8070.0%
Arrowhead Resh CorpCOM NEW042797209$6.2K3,114,7550.0%
Epizyme Inc(EPZMEUR)COM29428V104$4.2K151,0000.0%
Senomyx IncCOM81724Q107$2.1K975,6100.0%
Tranzyme IncCOM89413J102$1.3K2,700,0000.0%
Savient Pharmaceuticals IncNOTE 4.750% 2/080517QAA8$228$1,000,0000.0%